Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
171 studies found for:    fecal | Recruiting | Exclude Unknown | United States
Show Display Options
Rank Status Study
1 Recruiting Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
Condition: Fecal Incontinence
Interventions: Drug: Loperamide;   Drug: Placebo;   Behavioral: Anal exercises with biofeedback;   Behavioral: Usual Care
2 Recruiting Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing
Condition: Colon Cancer
Intervention: Device: Fecal Immunochemical Testing
3 Recruiting Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
Condition: Colorectal Cancer
Interventions: Procedure: Colonoscopy;   Procedure: FIT
4 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
5 Recruiting Fecal Transplant for Relapsing C. Difficile Infection
Condition: Clostridium Difficile
Interventions: Biological: Fecal Microbiota Transplantation;   Biological: Sham Fecal Microbiota Transplantation
6 Recruiting Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection
Condition: Clostridium Difficile Colitis
Interventions: Biological: FMT;   Biological: placebo
7 Recruiting FMT in Ulcerative Colitis-Associated Pouchitis
Condition: Ulcerative Colitis Associated Pouchitis
Interventions: Biological: biologically active human fecal microbiota;   Procedure: sigmoidoscopy
8 Recruiting Beans/Bran Enriching Nutritional Eating For Intestinal Health Trial
Condition: Colorectal Cancer Control and Prevention
Interventions: Dietary Supplement: Placebo-Control Meals and Snacks;   Dietary Supplement: Cooked Navy Bean Powder Meals and Snacks;   Dietary Supplement: Rice Bran Meals and Snacks
9 Recruiting 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea
Interventions: Drug: Ibodutant 10 mg;   Drug: Placebo
10 Recruiting 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea
Interventions: Drug: Ibodutant 10 mg;   Drug: Placebo
11 Recruiting Fecal Microbiota Transplantation in Pediatric Patients
Conditions: Inflammatory Bowel Diseases (IBD);   Crohn's Disease (CD);   Ulcerative Colitis (UC)
Intervention: Biological: Fecal Microbiota Transplantation (FMT)
12 Recruiting Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
Condition: Recurrent Clostridium Difficile Infection
Interventions: Biological: RBX2660 (microbiota suspension);   Other: Placebo
13 Recruiting Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbiota Transplant
14 Recruiting Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection
Condition: Clostridium Difficile
Intervention: Biological: Fecal Microbiota Transplantation
15 Recruiting Fecal Microbiota Transplantation in HIV
Condition: HIV
Intervention: Drug: Fecal Microbiota
16 Recruiting Autologous Fecal Therapy
Condition: Infectious Disease of Digestive Tract
Intervention: Biological: Autologous fecal microbiota therapy
17 Recruiting The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbial Transplant
18 Recruiting Fecal Microbial Transplant in Pediatric Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: Fecal Microbial transplant;   Drug: Normal Saline;   Drug: rifaximin+omeprazole+miralax
19 Recruiting Fecal Microbiota Transplantation for C Diff Infection
Condition: Clostridium Difficile Infection
Intervention: Biological: Human fecal matter
20 Recruiting Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Biological: fecal microbiota transplantation (FMT);   Other: No fecal microbiota transplantation (FMT), routine management

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years